Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Emergent Biosolutions (NY: EBS ) 8.770 -0.350 (-3.84%) Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Emergent Biosolutions < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Emergent BioSolutions Announces CEO Transition June 27, 2023 From Emergent BioSolutions Via GlobeNewswire Better Recovery-Story Buy: Emergent BioSolutions or Invitae? June 26, 2023 Both of these stocks have plummeted more than 50% over the past year. Via The Motley Fool Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data June 20, 2023 Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in Via Benzinga Is Emergent BioSolutions Stock a Buy Now? June 09, 2023 The deluge of bad news seems to be over, and a recovery could be in the works. Via The Motley Fool Down 75%, Can Emergent BioSolutions Turn Things Around? June 07, 2023 Has the stock finally bottomed out? Via The Motley Fool What 4 Analyst Ratings Have To Say About Emergent BioSolutions May 31, 2023 Via Benzinga Recap: Emergent BioSolutions Q1 Earnings May 09, 2023 Via Benzinga Why Emergent BioSolutions Stock Is Soaring Today March 30, 2023 Emergent received a key approval from the FDA, but just how good is this news? Via The Motley Fool FDA Approves First OTC Naloxone Nasal Spray For Opioid Overdose March 29, 2023 Via Benzinga Nasal-Spray Millionaire: Indivior's Opvee Nasal Spray Gets FDA Green Light for Opioid Overdose Treatment May 23, 2023 The FDA has approved Indivior PLC's (OTC: INVVY) Opvee (nalmefene) nasal spray for the emergency treatment of opioid overdose in adults and pediatric patients aged 12 years and older. Via Benzinga Why Emergent BioSolutions Stock Inched Slightly Higher Today May 15, 2023 Investors approved, if not enthusiastically, their company's latest asset sale. Via The Motley Fool Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic May 15, 2023 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 25, 2023 at 9:00am EDT May 11, 2023 From Emergent BioSolutions Via GlobeNewswire Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 12, 2023 Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,... Via Benzinga Emergent BioSolutions (EBS) Q1 2023 Earnings Call Transcript May 10, 2023 EBS earnings call for the period ending March 31, 2023. Via The Motley Fool Emergent BioSolutions Reports Financial Results For First Quarter 2023 May 09, 2023 From Emergent BioSolutions Via GlobeNewswire Emergent Plans $50 Price Point For Narcan OTC Version For Opioid Overdose Reversal April 21, 2023 Emergent BioSolutions Inc (NYSE: EBS) looks to price its over-the-counter (OTC) version of its opioid overdose reversal Narcan at around $50 per carton of two 4 mg doses. Via Benzinga Emergent BioSolutions to Release First Quarter 2023 Financial Results and Conduct Conference Call on May 9, 2023 April 19, 2023 From Emergent BioSolutions Via GlobeNewswire CPI Sent Market Surging - But Some Stocks Took A Hit: Spotlight On Top Gainers And Hard-Hit Decliners April 12, 2023 The market is trading higher on Wednesday after the Labor Department reported the latest Consumer Price Index figure for the month of March. While most stocks are trading higher alongside the major... Via Benzinga Tesla, Apple, Riot Platforms, AMC, Emergent Biosolutions: Why These 5 Stocks Are Drawing Investors' Attention Today April 10, 2023 U.S. Via Benzinga Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move April 10, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023 April 10, 2023 Via Benzinga Micron Technology, Greenbrier Companies And Other Big Stocks Moving Higher On Monday April 10, 2023 U.S. stocks traded lower, with the Nasdaq Composite falling over 100 points on Monday. Here are some big stocks recording gains in today’s session. Via Benzinga Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 30, 2023 Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... Via Benzinga Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday March 30, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording losses in today’s session. Via Benzinga Emergent Biosciences (EBS) Stock Pops as FDA Approves Over-the-Counter Narcan March 29, 2023 EBS stock is on the move as Emergent Biosciences expects its opioid emergency drug to be available soon without a prescription. Via InvestorPlace FDA Approves Over The Counter Sale Of Opioid Reversal Drug Narcan March 29, 2023 Narcan, the prescription nasal spray that reverses opioid overdoses can now be sold over the counter (OTC), said the FDA on Wednesday, reported the NY Times, thereby authorizing a move that has... Via Benzinga U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment March 29, 2023 From Emergent BioSolutions Via GlobeNewswire Why Emergent Biosolutions Stock Is Surging Today March 29, 2023 Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher Wednesday following reports the U.S. Food and Drug Administration approved the company's Naloxone nasal spray for over-the-counter use. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 29, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
